Showing 1 - 20 results of 71,823 for search '(( 5 non decrease ) OR ( 5 ((((we decrease) OR (greater decrease))) OR (_ decrease)) ))', query time: 1.19s Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    Rcan2-mediated decrease in intracellular K<sup>+</sup> involves Kcnk5b. by Xiaowen Jiang (8291814)

    Published 2024
    Subjects: “…observed coordinated decreases…”
  5. 5

    Image1_Decreased mitochondrial respiration associates with frailty in community-dwelling older adults.jpg by Gianella Liabeuf (18512634)

    Published 2024
    “…We observed that OCR was significantly decreased in frail men (p < 0.01). …”
  6. 6
  7. 7
  8. 8
  9. 9

    DataSheet2_Treatment of wild-type mice with 2,3-butanediol, a urinary biomarker of Fmo5−/− mice, decreases plasma cholesterol and epididymal fat deposition.pdf by Sunil Veeravalli (5074115)

    Published 2022
    “…<p>We previously showed that Fmo5<sup>−/−</sup> mice exhibit a lean phenotype and slower metabolic ageing. …”
  10. 10

    DataSheet1_Treatment of wild-type mice with 2,3-butanediol, a urinary biomarker of Fmo5−/− mice, decreases plasma cholesterol and epididymal fat deposition.PDF by Sunil Veeravalli (5074115)

    Published 2022
    “…<p>We previously showed that Fmo5<sup>−/−</sup> mice exhibit a lean phenotype and slower metabolic ageing. …”
  11. 11
  12. 12
  13. 13
  14. 14

    Data_Sheet_1_Effectiveness of non-pharmaceutical interventions in nine fields of activity to decrease SARS-CoV-2 transmission (Spain, September 2020–May 2021).PDF by Inés Barbeito (5864351)

    Published 2023
    “…Background<p>We estimated the association between the level of restriction in nine different fields of activity and SARS-CoV-2 transmissibility in Spain, from 15 September 2020 to 9 May 2021.…”
  15. 15
  16. 16

    Table_1_Cysteinyl Leukotriene Receptor Antagonists Associated With a Decreased Incidence of Cancer: A Retrospective Cohort Study.docx by Ha Young Jang (1522204)

    Published 2022
    “…Cox proportional hazard regression analysis was conducted to estimate the hazard ratios (HRs) for cancer risk of LTRA users.</p>Result<p>We followed-up (median: 5.6 years) 188,906 matched patients (94,453 LTRA users and 94,453 non-users). …”
  17. 17
  18. 18
  19. 19
  20. 20